William Blair Initiates Coverage On Riskified with Outperform Rating

William Blair analyst Robert Napoli initiates coverage on Riskified (NYSE:RSKD) with a Outperform rating.

William Blair analyst Robert Napoli initiates coverage on Riskified (NYSE:RSKD) with a Outperform rating.

Total
0
Shares
Related Posts
Read More

AstraZeneca’s Covid-19 Vaccine, Vaxzevria Has Been Granted Approval in the European Union by the European Medicine Agency as a Third Dose Booster in Adults.

AstraZeneca's COVID-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]), has been granted approval in the European Union (EU) by the European Medicine Agency (EMA) as a third dose booster in adults. Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine schedule of either Vaxzevria or an EU-approved mRNA COVID-19 vaccine.

AZN